Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Inhibition of endothelial cell Ca²⁺ entry and transient receptor potential channels by Sigma-1 receptor ligands.

Amer MS, McKeown L, Tumova S, Liu R, Seymour VA, Wilson LA, Naylor J, Greenhalgh K, Hou B, Majeed Y, Turner P, Sedo A, O'Regan DJ, Li J, Bon RS, Porter KE, Beech DJ.

Br J Pharmacol. 2013 Mar;168(6):1445-55. doi: 10.1111/bph.12041.

2.

Rapid and contrasting effects of rosiglitazone on transient receptor potential TRPM3 and TRPC5 channels.

Majeed Y, Bahnasi Y, Seymour VA, Wilson LA, Milligan CJ, Agarwal AK, Sukumar P, Naylor J, Beech DJ.

Mol Pharmacol. 2011 Jun;79(6):1023-30. doi: 10.1124/mol.110.069922. Epub 2011 Mar 15.

3.

Stereo-selective inhibition of transient receptor potential TRPC5 cation channels by neuroactive steroids.

Majeed Y, Amer MS, Agarwal AK, McKeown L, Porter KE, O'Regan DJ, Naylor J, Fishwick CW, Muraki K, Beech DJ.

Br J Pharmacol. 2011 Apr;162(7):1509-20. doi: 10.1111/j.1476-5381.2010.01136.x.

4.

Modulation of TRPC5 cation channels by halothane, chloroform and propofol.

Bahnasi YM, Wright HM, Milligan CJ, Dedman AM, Zeng F, Hopkins PM, Bateson AN, Beech DJ.

Br J Pharmacol. 2008 Apr;153(7):1505-12. doi: 10.1038/sj.bjp.0707689. Epub 2008 Jan 21.

5.

Inhibitory effects of AG490 on H2O2-induced TRPM2-mediated Ca(2+) entry.

Shimizu S, Yonezawa R, Hagiwara T, Yoshida T, Takahashi N, Hamano S, Negoro T, Toda T, Wakamori M, Mori Y, Ishii M.

Eur J Pharmacol. 2014 Nov 5;742:22-30. doi: 10.1016/j.ejphar.2014.08.023. Epub 2014 Aug 30.

PMID:
25179574
6.

Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7.

Chubanov V, Mederos y Schnitzler M, Meißner M, Schäfer S, Abstiens K, Hofmann T, Gudermann T.

Br J Pharmacol. 2012 Jun;166(4):1357-76. doi: 10.1111/j.1476-5381.2012.01855.x.

7.

Stimulation of TRPC5 cationic channels by low micromolar concentrations of lead ions (Pb2+).

Sukumar P, Beech DJ.

Biochem Biophys Res Commun. 2010 Feb 26;393(1):50-4. doi: 10.1016/j.bbrc.2010.01.074. Epub 2010 Jan 25.

8.

Sigma-1 receptor stimulation attenuates calcium influx through activated L-type Voltage Gated Calcium Channels in purified retinal ganglion cells.

Mueller BH 2nd, Park Y, Daudt DR 3rd, Ma HY, Akopova I, Stankowska DL, Clark AF, Yorio T.

Exp Eye Res. 2013 Feb;107:21-31. doi: 10.1016/j.exer.2012.11.002. Epub 2012 Nov 23.

9.

Involvement of TRP channels in the CO₂ chemosensitivity of locus coeruleus neurons.

Cui N, Zhang X, Tadepalli JS, Yu L, Gai H, Petit J, Pamulapati RT, Jin X, Jiang C.

J Neurophysiol. 2011 Jun;105(6):2791-801. doi: 10.1152/jn.00759.2010. Epub 2011 Mar 23.

10.

σ-1 Receptor agonist SKF10047 inhibits glutamate release in rat cerebral cortex nerve endings.

Lu CW, Lin TY, Wang CC, Wang SJ.

J Pharmacol Exp Ther. 2012 May;341(2):532-42. doi: 10.1124/jpet.111.191189. Epub 2012 Feb 22.

11.

Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction.

Tchedre KT, Huang RQ, Dibas A, Krishnamoorthy RR, Dillon GH, Yorio T.

Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4993-5002. doi: 10.1167/iovs.08-1867. Epub 2008 Jul 18.

PMID:
18641291
12.

Activation of the melastatin-related cation channel TRPM3 by D-erythro-sphingosine [corrected].

Grimm C, Kraft R, Schultz G, Harteneck C.

Mol Pharmacol. 2005 Mar;67(3):798-805. Epub 2004 Nov 18. Erratum in: Mol Pharmacol. 2005 Apr;67(4):1382.

14.

Transient receptor potential canonical type 3 channels facilitate endothelium-derived hyperpolarization-mediated resistance artery vasodilator activity.

Senadheera S, Kim Y, Grayson TH, Toemoe S, Kochukov MY, Abramowitz J, Housley GD, Bertrand RL, Chadha PS, Bertrand PP, Murphy TV, Tare M, Birnbaumer L, Marrelli SP, Sandow SL.

Cardiovasc Res. 2012 Sep 1;95(4):439-47. doi: 10.1093/cvr/cvs208. Epub 2012 Jun 21.

15.

Functional TRP and ASIC-like channels in cultured urothelial cells from the rat.

Kullmann FA, Shah MA, Birder LA, de Groat WC.

Am J Physiol Renal Physiol. 2009 Apr;296(4):F892-901. doi: 10.1152/ajprenal.90718.2008. Epub 2009 Jan 21.

16.

Riluzole activates TRPC5 channels independently of PLC activity.

Richter JM, Schaefer M, Hill K.

Br J Pharmacol. 2014 Jan;171(1):158-70. doi: 10.1111/bph.12436.

17.

Production of a specific extracellular inhibitor of TRPM3 channels.

Naylor J, Milligan CJ, Zeng F, Jones C, Beech DJ.

Br J Pharmacol. 2008 Oct;155(4):567-73. doi: 10.1038/bjp.2008.283. Epub 2008 Jul 7.

18.

Ca2+-calmodulin-dependent myosin light chain kinase is essential for activation of TRPC5 channels expressed in HEK293 cells.

Shimizu S, Yoshida T, Wakamori M, Ishii M, Okada T, Takahashi M, Seto M, Sakurada K, Kiuchi Y, Mori Y.

J Physiol. 2006 Jan 15;570(Pt 2):219-35. Epub 2005 Nov 10.

19.

Fenamates as TRP channel blockers: mefenamic acid selectively blocks TRPM3.

Klose C, Straub I, Riehle M, Ranta F, Krautwurst D, Ullrich S, Meyerhof W, Harteneck C.

Br J Pharmacol. 2011 Apr;162(8):1757-69. doi: 10.1111/j.1476-5381.2010.01186.x.

20.

TRPC5 channel sensitivities to antioxidants and hydroxylated stilbenes.

Naylor J, Al-Shawaf E, McKeown L, Manna PT, Porter KE, O'Regan D, Muraki K, Beech DJ.

J Biol Chem. 2011 Feb 18;286(7):5078-86. doi: 10.1074/jbc.M110.196956. Epub 2010 Dec 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk